AJOG Global Reports (Aug 2024)

A tale of two societies: implications of conflicting Rh-immunoglobulin guidelines

  • Cara Heuser, MD, MS,
  • Rachel Flink-Bochacki, MD, MPH,
  • Jeffrey Sperling, MD,
  • Katharine Simmons, MD, MPH,
  • Kirsten Salmeen, MD

Journal volume & issue
Vol. 4, no. 3
p. 100380

Abstract

Read online

National guidance conflicts regarding the use of RhD immune globulin administration <12w. Recent Society for Maternal Fetal Medicine (SMFM) guidelines suggest liberal use of this product while other guidelines, including Society of Family Planning and the World Health Organization, propose a more conservative approach. Medicine is not practiced in a vacuum, and potential harms must include not only individual but communal and public health effects. We aim to critically examine the practical implications of the new SMFM guidelines with a focus on equity and access.

Keywords